Steven M. Pieper serves as the Chief Financial Officer at Xeris Biopharma Holdings Inc., a specialty pharmaceutical company focused on developing and commercializing innovative therapies for patient populations with significant unmet medical needs. In his role as CFO, Pieper is responsible for overseeing the financial operations and strategy of the company, ensuring its fiscal health and growth. His leadership has been instrumental in guiding Xeris through various stages of development, from clinical trials to commercialization of their products. Prior to joining Xeris Biopharma Holdings Inc., Pieper held several senior financial positions at various life sciences and healthcare companies. He has a proven track record of successfully managing financial operations, strategic planning, and capital raising efforts. Pieper's extensive experience in the industry has equipped him with the skills necessary to navigate the complex financial landscape of the biopharmaceutical sector. His strategic vision and financial acumen have been key factors in Xeris' ability to advance its pipeline and expand its market presence. Under Pieper's financial stewardship, Xeris Biopharma has achieved significant milestones, including the successful launch of its first commercial product and the expansion of its product portfolio. His ability to forge strong relationships with investors and stakeholders has been crucial in securing the funding necessary for the company's growth. Pieper's dedication to excellence and his commitment to the company's mission of improving patient outcomes have made him an invaluable asset to Xeris Biopharma Holdings Inc.